Digital Biomarkers Market Size (2024 - 2029)

Digital Biomarkers Market Analysis

The Digital Biomarkers Market size is estimated at USD 3.64 billion in 2024, and is expected to reach USD 9.02 billion by 2029, growing at a CAGR of 19.90% during the forecast period (2024-2029).

The major factors driving market growth include the growing number of clinical trials and technological advancements in digital biomarkers.

The increasing prevalence of chronic diseases in developing countries and developed countries is anticipated to support the use of digital biomarkers for remote patient monitoring. According to the Centers for Disease Control and Prevention, the percentage of coronary heart disease for adults aged 18 and over in the United States was 4.9% in 2022.

Moreover, market players' introduction of innovative and easy-to-use wearables and software to detect various vital signs is augmenting the demand for digital biomarkers. For instance, in November 2022, Shimmer Research launched its Verisense Digital Health Panel (DHP) to provide clinical researchers with unprocessed, real-world sensor data, enhancing their insights.

The sensor data will be integrated with patient-reported outcomes and various real-world sources, such as tokenized medical records, claims, and pharmacy data. This will facilitate the development of standardized digital biomarkers and endpoints, enhancing confidence and trust among regulators, payors, and patients, thereby boosting market growth.

The increasing number of clinical trials, the growth in research investments, and the development of various therapeutics to manage chronic conditions are expected to drive the demand for digital tools, including digital biomarkers. According to clinicaltrials.gov, 20,189 clinical trials were active in June 2024. The large number of ongoing clinical trials is accountable for the surge in demand for digital biomarkers.

Therefore, owing to the factors mentioned above, the market is anticipated to witness growth over the forecast period. However, high product costs and data security concerns are expected to hinder market growth.

Digital Biomarkers Industry Segmentation

Digital biomarkers are digital devices such as portables, wearables, implantables, or digestibles used to collect objective, quantifiable physiological and behavioral data. The data collected is used mainly to understand health-related outcomes.

The digital biomarkers market is segmented by type, clinical practice, therapeutic area, end user, and geography. By type, the market is segmented into data collection tools and data integration tools. By clinical practice, the market is segmented into monitoring digital biomarkers, diagnostic digital biomarkers, predictive and prognostic digital biomarkers, and other clinical practices. By therapeutic area, the market is segmented into cardiovascular and metabolic disorders, respiratory disorders, neurological disorders, musculoskeletal disorders, and other therapeutic areas. By end user, the market is segmented into pharmaceutical companies, healthcare providers, payers, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the values (USD) for all the above segments.